Pharmaceutical composition containing novel spiro compound

JP2024159693APending Publication Date: 2024-11-08TANABE PHARMA CORP
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
JP2024072088
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-04-28
Filing Date
2024-04-26
Publication Date
2024-11-08

Smart Images

  • Figure 2024159693000001
    Figure 2024159693000001
  • Figure 2024159693000002
    Figure 2024159693000002
  • Figure 2024159693000003
    Figure 2024159693000003
Patent Text Reader

Abstract

To provide a pharmaceutical composition or the like that contains novel spiro compound which has inhibitory activity of TRH-DE, and is useful for preventing / treating TRH-involved various diseases and / or symptoms associated with the diseases, or a pharmacologically acceptable salt thereof as an active ingredient.SOLUTION: A pharmaceutical composition contains a compound expressed by a general formula [I]: [in the formula, a ring A denotes substituted / unsubstituted aryl, substituted / unsubstituted heteroaryl, substituted / unsubstituted aliphatic heterocycle; R1, R2 denote substituted / unsubstituted alkyl, substituted / unsubstituted cycloalkyl group, substituted / unsubstituted alkenyl, substituted / unsubstituted cycloalkenyl, substituted / unsubstituted alkynyl, substituted / unsubstituted aryl, substituted / unsubstituted heteroaryl, substituted / unsubstituted aliphatic heterocyclic group which may include double bond in a part of the ring, substituted / unsubstituted amino group or the like], or a pharmacologically acceptable salt thereof as an active ingredient.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • TRH-like peptide derivatives as inhibitors of the TRH-degrading ectoenzyme

    WO2001060843A1

  • Compounds that modulate TRH actions and inhibit the TRH-degrading enzyme

    WO2006038206A2

  • Methods for modulating the levels and effects of thyrotropin-releasing hormone (TRH) and TRH-related petides

    WO2007113784A2